Gene Expression Profiling in Human Gastric Intestinal Metaplasia Mucosa and Duodenal Mucosa

To analyze the genome pattern in human gastric Intestinal Metaplasia Mucosa and duodenal Mucosa.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Gene Expression Profiling Duodenum Gastric Intestinal Metaplasia

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Gastroenterology, Qilu Hospital, Shandong University

Jinan, Shandong, 250012, China

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients scheduled for gastroendoscopy examination

Exclusion criteria

Esophageal, gastric or duodenal cancer or other malignancy History of upper GI tract surgery Coagulopathy or bleeding disorders Allergy to fluorescein sodium

Treatment and study plan

Primary outcomes

Gene Expression Profiling in Human Gastric Intestinal Metaplasia Mucosa and Duodenal Mucosa

Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Shandong University

Other

Registry information

Official study title

Gene Expression Profiling in Human Gastric Intestinal Metaplasia Mucosa and Duodenal Mucosa.

Important dates

Study start: 2014
Primary completion: 2015
Study completion: 2015
First posted: Jul 27, 2016
Registry last updated: Jul 27, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed